International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 3 , Pages 670-676, 1 July 2010

Chemoradiotherapy of Newly Diagnosed Glioblastoma With Intensified Temozolomide

Presented orally at the Eighth Meeting of the European Association of Neuro-Oncology, September 12–14, 2008, Barcelona, Spain.

  • Markus Weiler, M.D.

      Affiliations

    • Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
    • Department of Neurooncology, University of Heidelberg, Heidelberg, Germany
    • ,
  • Christian Hartmann, M.D.

      Affiliations

    • Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany
    • ,
  • Dorothee Wiewrodt, M.D.

      Affiliations

    • Department of Neurosurgery, University of Mainz, Mainz, Germany
    • ,
  • Ulrich Herrlinger, M.D.

      Affiliations

    • Clinical Neurooncology Unit, Department of Neurology, University of Bonn, Bonn, Germany
    • ,
  • Thierry Gorlia, M.Sc.

      Affiliations

    • European Organization for Research and Treatment of Cancer Data Centre, Brussels, Belgium
    • ,
  • Oliver Bähr, M.D.

      Affiliations

    • Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
    • ,
  • Richard Meyermann, M.D.

      Affiliations

    • Department of Neuropathology, University of Tübingen, Tübingen, Germany
    • ,
  • Michael Bamberg, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Tübingen, Tübingen, Germany
    • ,
  • Marcos Tatagiba, M.D.

      Affiliations

    • Department of Neurosurgery, University of Tübingen, Tübingen, Germany
    • ,
  • Andreas von Deimling, M.D.

      Affiliations

    • Department of Neuropathology, University of Heidelberg, Heidelberg, Germany
    • ,
  • Michael Weller, M.D.

      Affiliations

    • Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
    • Department of Neurology, University Hospital of Zurich, Zurich, Switzerland
    • ,
  • Wolfgang Wick, M.D.

      Affiliations

    • Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
    • Department of Neurooncology, University of Heidelberg, Heidelberg, Germany
    • Corresponding Author InformationReprint requests to: Wolfgang Wick, M.D., Department of Neurooncology, University of Heidelberg, Im Neuenheimer Feld 400, Heidelberg D-69120 Germany. Tel: (+49) 6221-56-7075; Fax: (+49) 6221-56-7554

Received 23 February 2009; received in revised form 24 May 2009; accepted 26 May 2009. published online 15 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the University of Tübingen Medical Center, Tübingen, Germany.

 Conflict of interest: U. Herrlinger, M. Weller, and W. Wick have been consultants to, and have received honoraria from, Schering-Plough.

PII: S0360-3016(09)00794-9

doi:10.1016/j.ijrobp.2009.05.031

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 3 , Pages 670-676, 1 July 2010

Article Tools

* Image Usage & Resolution